173 related articles for article (PubMed ID: 36867447)
1. Endothelial mechanisms for inactivation of inflammation-induced hyperpermeability.
Nepali PR; Burboa PC; Lillo MA; Mujica PE; Iwahashi T; Zhang J; Durán RG; Boric M; Golenhofen N; Kim DD; Alves NG; Thomas AP; Breslin JW; Sánchez FA; Durán WN
Am J Physiol Heart Circ Physiol; 2023 May; 324(5):H610-H623. PubMed ID: 36867447
[TBL] [Abstract][Full Text] [Related]
2.
Zamorano P; Marín N; Córdova F; Aguilar A; Meininger C; Boric MP; Golenhofen N; Contreras JE; Sarmiento J; Durán WN; Sánchez FA
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H66-H71. PubMed ID: 28526707
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cAMP deactivates ischemia-reperfusion-induced microvascular hyperpermeability via Rap1-mediated mechanisms.
Korayem AH; Mujica PE; Aramoto H; Durán RG; Nepali PR; Kim DD; Harris AL; Sánchez FA; Durán WN
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H179-H189. PubMed ID: 28476918
[TBL] [Abstract][Full Text] [Related]
4. S-Nitrosation of β-catenin and p120 catenin: a novel regulatory mechanism in endothelial hyperpermeability.
Marín N; Zamorano P; Carrasco R; Mujica P; González FG; Quezada C; Meininger CJ; Boric MP; Durán WN; Sánchez FA
Circ Res; 2012 Aug; 111(5):553-63. PubMed ID: 22777005
[TBL] [Abstract][Full Text] [Related]
5. Internalization of eNOS via caveolae regulates PAF-induced inflammatory hyperpermeability to macromolecules.
Sánchez FA; Kim DD; Durán RG; Meininger CJ; Durán WN
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1642-8. PubMed ID: 18708444
[TBL] [Abstract][Full Text] [Related]
6. Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability.
Sánchez FA; Rana R; González FG; Iwahashi T; Durán RG; Fulton DJ; Beuve AV; Kim DD; Durán WN
J Biol Chem; 2011 Sep; 286(35):30409-30414. PubMed ID: 21757745
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase regulates microvascular hyperpermeability in vivo.
Hatakeyama T; Pappas PJ; Hobson RW; Boric MP; Sessa WC; Durán WN
J Physiol; 2006 Jul; 574(Pt 1):275-81. PubMed ID: 16675496
[TBL] [Abstract][Full Text] [Related]
8. Internalization of eNOS and NO delivery to subcellular targets determine agonist-induced hyperpermeability.
Sánchez FA; Rana R; Kim DD; Iwahashi T; Zheng R; Lal BK; Gordon DM; Meininger CJ; Durán WN
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6849-53. PubMed ID: 19342481
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
10. Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis.
Brkovic A; Sirois MG
J Cell Biochem; 2007 Feb; 100(3):727-37. PubMed ID: 17115409
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
12. Vasodilator-stimulated phosphoprotein deficiency potentiates PAR-1-induced increase in endothelial permeability in mouse lungs.
Profirovic J; Han J; Andreeva AV; Neamu RF; Pavlovic S; Vogel SM; Walter U; Voyno-Yasenetskaya TA
J Cell Physiol; 2011 May; 226(5):1255-64. PubMed ID: 20945373
[TBL] [Abstract][Full Text] [Related]
13. Functional significance of differential eNOS translocation.
Sánchez FA; Savalia NB; Durán RG; Lal BK; Boric MP; Durán WN
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1058-64. PubMed ID: 16679407
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo.
Kim DD; Kleinman DM; Kanetaka T; Gerritsen ME; Nivaggioli T; Weber D; Durán WN
Microcirculation; 2010 Feb; 17(2):128-36. PubMed ID: 20163539
[TBL] [Abstract][Full Text] [Related]
15. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms mediating protective effect of cAMP on lipopolysaccharide (LPS)-induced human lung microvascular endothelial cells (HLMVEC) hyperpermeability.
Bogatcheva NV; Zemskova MA; Kovalenkov Y; Poirier C; Verin AD
J Cell Physiol; 2009 Dec; 221(3):750-9. PubMed ID: 19725051
[TBL] [Abstract][Full Text] [Related]
17. Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier.
Waschke J; Burger S; Curry FR; Drenckhahn D; Adamson RH
Histochem Cell Biol; 2006 Apr; 125(4):397-406. PubMed ID: 16195887
[TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803
[TBL] [Abstract][Full Text] [Related]
19. In Vivo FRET Imaging of Tumor Endothelial Cells Highlights a Role of Low PKA Activity in Vascular Hyperpermeability.
Yamauchi F; Kamioka Y; Yano T; Matsuda M
Cancer Res; 2016 Sep; 76(18):5266-76. PubMed ID: 27488524
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to prevent endothelial hyperpermeability: the Crataegus extract WS® 1442 targets the cAMP/Rap1 pathway.
Bubik MF; Willer EA; Bihari P; Jürgenliemk G; Ammer H; Krombach F; Zahler S; Vollmar AM; Fürst R
J Mol Cell Cardiol; 2012 Jan; 52(1):196-205. PubMed ID: 22085704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
